Jump Main Menu. Go directly to the main content

Sección de idiomas


Fin de la sección de idiomas

Access / Registration

Sección de utilidades

Fin de la sección de utilidades



Start of main content

Felipe Calvo Frédérick Bordry

Ion beam therapy. Clinical and technological challenges for the next decade

Life and Matter Sciences Scientific Meeting Tuesday, 11 February 2020, 19:00 hours Madrid

General information:

Venue: Fundación Ramón Areces - Calle Vitruvio, 5. 28006. Madrid.

Free admission. Necessary previous online registration. Limited capacity. 

  • Description
  • Programme

Ten years ago, there were around 30 ion-beam therapy centers clinically active. In 2020, a number close to 100 will be operative. This trend has been boosted by the commercially availability of single and dual room proton beam facilities. In spite of this trend, there is still a controversy among the actual medical efficacy of this radiotherapy technique.

Other ions heavier than proton are expected to provide, in specific cases, even further clinical outcome, but the complexity and cost of such technology is currently an issue. Only ten per cent of the current clinical centers provide ion beam therapy.

This seminar will address the current status of proton and ion beam therapy, both from the clinical and technological viewpoints. The first lecture will cover medical aspects: status of proton and ion beam therapy, steps for a clinical consolidation and carbon versus proton therapy. The second lecture will analyze technological aspects of proton and ion beam facilities, technological needs for a clinical implementation of carbon and other ions beam therapy and current R&D actions under consideration for the next decade at European level on this topic.

Tuesday, 11 February

18:30 h.

Attendees check-in

19:00 h.


Manuel Aguilar Benítez de Lugo
Scientific Council. Fundación Ramón Areces.


Proton and Ion beam therapy. Clinical facts and open points for a practical deploy

Felipe Calvo
Clínica Universidad de Navarra.


Proton and Ion beam therapy. Technological status and demanded advances in the next decade 

Frédérick Bordry 
Laboratorio Europeo para la Investigación Nuclear, CERN.



Chairman: José Manuel Pérez
Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT).

Felipe Calvo is Chair Professor of Radiation Oncology at the University of Navarra (Spain), Co-Chairman of the Oncology Department and Director of the Proton Therapy Center in Madrid Campus. Dr. Calvo was trained in cancer proton therapy at Mayo Clinic Rochester and MD Anderson Hospital in Houston. Recently, was involved as clinical consultant for the Health Council of the Community of Madrid analyzing the potential of an ion project devoted to medical use. His areas of interest in oncology are precision radiotherapy techniques, tumor response assessment to chemo-radiation and innovative tools for image-guided precise radiotherapy. As Coordinator of Research and Education Unit at Clínica Universidad de Navarra in Madrid Campus, Dr. Calvo promotes academic interdisciplinary projects in clinical development focused in a patient centered medical care approach. Particle therapy in cancer medicine emerges as a unique opportunity to test the impact of dosimetric benefit into clinical benefit in the context with new radiobiological paradigms in normal tissue tolerance, tumor control and radio-immunogenicity.

Frédérick Bordry is the CERN’s Director for Accelerators and Technology since January 2014. He is responsible for the operation and exploitation of the whole CERN accelerator complex, with particular emphasis on the LHC and for the development of new technologies for post-LHC projects. He holds a PhD in electrical engineering and a state doctorate in energy conversion. After a two-year teaching post at the Federal University of Santa Catarina (Brazil), he took up a teaching and research post in Toulouse before joining the CERN in 1986. From 1994, he played a key role in the design and construction of CERN’s flagship particle accelerator, the Large Hadron Collider (LHC), which made possible the discovery of the Higgs boson in 2012. From 2016, he is the Chair of the CERN Medical Applications Steering Committee (CMASC).

  • Activities related
  • Projects related
  • News related
  • Publications related

see all

End of main content